<DOC>
	<DOCNO>NCT01309984</DOCNO>
	<brief_summary>The purpose study ass transfer fospropofol active metabolite , propofol , breast milk follow administration LUSEDRA® lactate woman undergo needed procedure .</brief_summary>
	<brief_title>A Study Assess Transfer Fospropofol Its Active Metabolite , Propofol , Breast Milk Following Administration LUSEDRA Lactating Women Undergoing Needed Procedure</brief_title>
	<detailed_description>E2083 , LUSEDRA® ( fospropofol disodium ) Injection , intravenous ( IV ) sedative-hypnotic agent indicate monitor anesthesia care ( MAC ) sedation adult patient undergoing diagnostic therapeutic procedures.1 It water-soluble , phosphono-O-methyl prodrug propofol . Upon IV injection , inactive fospropofol undergoes metabolism , notably alkaline phosphatase enzyme , yield active metabolite ( propofol ) , phosphate , formaldehyde . Formaldehyde quickly convert formate vivo , formate metabolize folate-dependent mechanism .</detailed_description>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Fospropofol</mesh_term>
	<criteria>Inclusions : Lactating woman undergo needed procedure expect last approximately 10 45 minute Subjects 6 week 8 month postpartum Lactation must wellestablished subject Subject 's infant must full term able bottlefeed Infants predominantly breast milk feed receive one bottle formula per day Exclusions : Subjects pregnant Subjects undergo breast procedure ( eg , biopsy , abscess drainage , etc . ) Subjects willing temporarily refrain nursing child 024 hour breast milk collection interval . ( Subjects may resume nurse follow interval ) .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Monitored anesthesia care</keyword>
</DOC>